DK1135503T3 - Lægemiddel-targets i candida albicans - Google Patents
Lægemiddel-targets i candida albicansInfo
- Publication number
- DK1135503T3 DK1135503T3 DK99966952T DK99966952T DK1135503T3 DK 1135503 T3 DK1135503 T3 DK 1135503T3 DK 99966952 T DK99966952 T DK 99966952T DK 99966952 T DK99966952 T DK 99966952T DK 1135503 T3 DK1135503 T3 DK 1135503T3
- Authority
- DK
- Denmark
- Prior art keywords
- candida albicans
- drug targets
- growth
- genes
- critical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/40—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98204122 | 1998-12-04 | ||
| PCT/EP1999/009833 WO2000034481A2 (en) | 1998-12-04 | 1999-12-06 | DRUG TARGETS IN $i(CANDIDA ALBICANS) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1135503T3 true DK1135503T3 (da) | 2007-06-18 |
Family
ID=8234434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99966952T DK1135503T3 (da) | 1998-12-04 | 1999-12-06 | Lægemiddel-targets i candida albicans |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7125970B1 (da) |
| EP (1) | EP1135503B1 (da) |
| JP (1) | JP2004500016A (da) |
| AT (1) | ATE354658T1 (da) |
| AU (1) | AU773378B2 (da) |
| CA (1) | CA2353525A1 (da) |
| DE (1) | DE69935247T2 (da) |
| DK (1) | DK1135503T3 (da) |
| ES (1) | ES2283147T3 (da) |
| IL (1) | IL143494A0 (da) |
| NZ (1) | NZ511410A (da) |
| WO (1) | WO2000034481A2 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6783985B1 (en) | 2000-02-18 | 2004-08-31 | Elitra Pharmaceuticals Inc. | Gene disruption methodologies for drug target discovery |
| CN104342375A (zh) * | 2013-07-31 | 2015-02-11 | 中国科学院上海生命科学研究院 | 一种白念珠菌smt3基因的用途及缺失smt3基因的白念珠菌减毒株 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL100908A0 (en) * | 1991-02-22 | 1992-11-15 | Salk Inst Biotech Ind | Invertase genes and their use |
| IT1282287B1 (it) * | 1995-05-16 | 1998-03-16 | Ist Superiore Sanita | La sequenza del dna completo dell'inserto carlubo codificante per una proteina heat shch di forda (cansp 70) di candida albicans ceppo atcc |
| EP0904289A4 (en) * | 1996-04-01 | 2001-12-12 | Anadys Pharmaceuticals Inc | CANDIDA ALBICANS TATA FIXING PROTEIN, NUCLEIC ACID ENCODING IT, AND SELECTED TESTS |
| US5863762A (en) * | 1996-04-01 | 1999-01-26 | Scriptgen Pharm Inc | Nucleic acids encoding TFIIB transcription factor from candida albicans |
| US5827692A (en) * | 1997-04-24 | 1998-10-27 | Heska Corporation | Dirofilaria and Brugia ankyrin proteins, nucleic acid molecules, and uses thereof |
| US6747137B1 (en) * | 1998-02-13 | 2004-06-08 | Genome Therapeutics Corporation | Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics |
| WO2003099223A2 (en) * | 2002-05-24 | 2003-12-04 | The Regents Of The University Of Michigan | Copper lowering treatment of inflammatory and fibrotic diseases |
| US20050042646A1 (en) * | 2002-08-05 | 2005-02-24 | Davidson Beverly L. | RNA interference suppresion of neurodegenerative diseases and methods of use thereof |
-
1999
- 1999-12-06 IL IL14349499A patent/IL143494A0/xx unknown
- 1999-12-06 JP JP2000586914A patent/JP2004500016A/ja not_active Withdrawn
- 1999-12-06 WO PCT/EP1999/009833 patent/WO2000034481A2/en active IP Right Grant
- 1999-12-06 AT AT99966952T patent/ATE354658T1/de not_active IP Right Cessation
- 1999-12-06 ES ES99966952T patent/ES2283147T3/es not_active Expired - Lifetime
- 1999-12-06 AU AU22827/00A patent/AU773378B2/en not_active Ceased
- 1999-12-06 DE DE69935247T patent/DE69935247T2/de not_active Expired - Fee Related
- 1999-12-06 CA CA002353525A patent/CA2353525A1/en not_active Abandoned
- 1999-12-06 DK DK99966952T patent/DK1135503T3/da active
- 1999-12-06 EP EP99966952A patent/EP1135503B1/en not_active Expired - Lifetime
- 1999-12-06 US US09/857,372 patent/US7125970B1/en not_active Expired - Fee Related
- 1999-12-06 NZ NZ511410A patent/NZ511410A/en unknown
-
2006
- 2006-09-12 US US11/519,693 patent/US20070010448A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE69935247T2 (de) | 2007-10-31 |
| ES2283147T3 (es) | 2007-10-16 |
| WO2000034481A3 (en) | 2000-11-30 |
| IL143494A0 (en) | 2002-04-21 |
| DE69935247D1 (de) | 2007-04-05 |
| JP2004500016A (ja) | 2004-01-08 |
| AU773378B2 (en) | 2004-05-20 |
| AU2282700A (en) | 2000-06-26 |
| EP1135503B1 (en) | 2007-02-21 |
| ATE354658T1 (de) | 2007-03-15 |
| US20070010448A1 (en) | 2007-01-11 |
| US7125970B1 (en) | 2006-10-24 |
| CA2353525A1 (en) | 2000-06-15 |
| NZ511410A (en) | 2004-06-25 |
| EP1135503A2 (en) | 2001-09-26 |
| WO2000034481A2 (en) | 2000-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69942459D1 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
| ES2105698T3 (es) | Oligonucleotidos modificados con 7-deazapurina. | |
| ATE237312T1 (de) | In liposomen verkapselte nukleinsäurekomplexe | |
| BR0107536A (pt) | Rna isolado, extrato solúvel, método para produzir rna de cerca de 21 a cerca de 23 nucleotìdeos de comprimento; dna isolado | |
| HUP9901072A2 (hu) | Szintetikus emlőskromoszóma és eljárások előállítására | |
| ATE507300T1 (de) | Rekombinante konstrukte und ihre verwendung bei der reduzierung der genexpression | |
| DE69824597D1 (de) | Ikk-beta proteine, nukleinsäuren und verfahren | |
| WO2001048183A3 (en) | Improvements relating to double-stranded rna inhibition | |
| WO1998041648A3 (en) | Target genes for allele-specific drugs | |
| Hong et al. | A revision of the human XIST gene organization and structural comparison with mouse Xist | |
| BR9911349A (pt) | Genes para a biossìntese de epotilonas | |
| DK1175489T3 (da) | Oligonukleotider indeholdende en antisense-sekvens stabiliseret af en sekundær struktur og farmaceutiske præparater indeholdende disse oligonukleotider | |
| Rydberg et al. | Human cells contain protein specifically binding to a single 1, N6-ethenoadenine in a DNA fragment. | |
| ATE332379T1 (de) | Menschliche dnase resistent gegen actininhibitoren | |
| DK1135503T3 (da) | Lægemiddel-targets i candida albicans | |
| DK1693451T3 (da) | Fremgangsmåde til dyrkning af myokardieceller | |
| DE69728415D1 (de) | Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2) | |
| BR9806183A (pt) | Quinases de proteìna e usos das mesmas | |
| WO2004056965A3 (en) | Nucleic acids encoding antifungal drug targets and methods of use | |
| SE9900615L (sv) | Metod och kit för tidig förutsägelse av cancer | |
| WO1998024887A3 (en) | Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof | |
| Preiser et al. | Poly (U)-binding protein inhibits Drosophila pre-5 S RNA 3'-exonuclease digestion | |
| ATE386140T1 (de) | Methoden und reagenzien zur in situ amplifizierung | |
| Holst et al. | Posttranslational phosphorylation of specific chromosomal proteins and transcription of hnRNA genes in isolated nuclei: Retention of in vivo sensitivity to 5, 6‐dichloro‐1‐β‐D‐ribofuranosylbenzimidazole (DRB) | |
| WO2001020024A3 (de) | Verfahren zum ermitteln von nuklein- und/oder aminosäuresequenzen |